评估剥脱性点阵二氧化碳激光治疗烧伤相关供皮区瘢痕的经验教训
研究将20例患者的供皮区瘢痕随机分为接受6次剥脱性点阵二氧化碳激光治疗加随访和标准治疗组或仅标准治疗组,发现两组在经表皮水分丢失、弹性、红斑、黑素指数、细胞密度、网嵴比、表皮厚度及POSAS-O、POSAS-P、VSS、SCS评分上均无差异。作者认为剥脱性点阵二氧化碳激光可能不改变供皮区瘢痕的成熟和重塑速率,且供皮区瘢痕可能不适合作为烧伤瘢痕随机对照试验的替代模型。
要点
- 供皮区瘢痕随机接受6次点阵激光加标准治疗或仅标准治疗,各客观指标和评分均无差异。
- 烧伤瘢痕比供皮区和正常皮肤更严重,但本研究未对激光治疗的烧伤瘢痕设特定对照。
- 作者认为供皮区瘢痕可能不是评估点阵激光治疗烧伤瘢痕的合适随机对照试验模型。
核心结论
- 剥脱性点阵二氧化碳激光可能不改变供皮区瘢痕的成熟和重塑速率,与当前标准治疗相比无差异。
- 激光治疗的烧伤瘢痕观察到瘢痕评估改善,但未对这些部位分析特定对照。
- 由于移植部位和供皮区肥厚性瘢痕形成的病理生理差异,供皮区瘢痕可能不是评估剥脱性点阵二氧化碳激光效果的合适随机对照试验替代模型。
研究设计与样本
- 研究纳入20例患者,供皮区瘢痕随机接受6次剥脱性点阵二氧化碳激光治疗加随访和标准治疗或仅标准治疗。
- 治疗前评估供皮区皮肤和正常皮肤的经表皮水分丢失、黑素指数、弹性和红斑,并系列活检分析表皮厚度、网嵴比和真皮乳头细胞密度。
- 所有部位包括单独的烧伤瘢痕部位使用POSAS-O、POSAS-P、VSS和机构瘢痕比较量表评估。
主要发现
- 治疗前供皮区对照、供皮区治疗和烧伤瘢痕部位较正常皮肤色素沉着增加。
- 烧伤瘢痕较其他所有部位弹性降低,且较正常皮肤经表皮水分丢失增加。
- 供皮区皮肤较正常皮肤细胞密度增加、网嵴比降低、表皮厚度增加。
- 临床观察者和患者通过POSAS-O、POSAS-P和VSS认为烧伤瘢痕部位比供皮区皮肤更严重。
- 随时间推移,供皮区对照和供皮区治疗部位在经表皮水分丢失、弹性、红斑、黑素指数、细胞密度、网嵴比、表皮厚度、POSAS-O评分、POSAS-P评分、VSS评分或SCS评分上均无差异。
关键数值与推荐
- 随时间推移,烧伤瘢痕在经表皮水分丢失、弹性、红斑、黑素指数、POSAS-O评分、POSAS-P评分和VSS评分上无变化。
- 供皮区对照、供皮区治疗和烧伤瘢痕部位的SCS评分下降,表明患者感知所有瘢痕在研究时间过程中改善。
- 正常皮肤和供皮区皮肤存在固有生理差异,但未达到烧伤瘢痕与正常皮肤之间的程度。
临床怎么用
- 原文未据此给出推荐。
局限性
- 激光治疗的烧伤瘢痕观察到瘢痕评估改善,但未对这些部位分析特定对照。
- 先前评估剥脱性点阵二氧化碳激光治疗烧伤相关肥厚性瘢痕的研究由低把握度临床试验或无对照部位或组织水平检查的病例研究组成。
- 供皮区瘢痕可能不适合该研究设计。
- 未来工作应扩展到供皮区和烧伤瘢痕愈合的细胞外基质形态学和转录组学,以更好理解激光治疗的效果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Hypertrophic scar (HTS) remains a comorbidity of burn injury, often requiring split-thickness skin grafting (STSG) and resulting in symptomatic HTS at grafted sites and STSG donor sites (DS). Literature supports the use of ablative fractional CO2 laser (FLSR) to treat HTS, however many trials lack control sites and tissue-level examinations. Given the widespread adoption of FLSR for HTS, delegation of non-treated scar sites for the sake of randomized controlled trials (RCT) is troubling for many clinicians. We trialed using STSG DS scars for randomization rather than withholding FLSR from HTS at grafted sites. Patients (n = 20) were treated for DS scar with FLSR. DS scars were randomized and treated with either 6 FLSR treatments, follow-ups, and standard of care (SOC) or SOC only. Prior to treatment, DS skin and normal skin (NS) were evaluated for trans-epidermal water loss (TEWL), melanin index (MI), elasticity, and erythema. Serial biopsies were analyzed for epidermal thickness, rete ridge ratio (RRR), and papillary dermal cellularity. All sites, including a separate burn scar (BS) site, were evaluated using the patient and observer scar assessment scale (POSAS) -observer (-O), -patient (-P), Vancouver Scar Scale (VSS), and an institutional Scar Comparison Scale (SCS). Prior to treatment, the DS control (DS C), DS treated (DS T), and BS sites were hyperpigmented compared to normal skin. BS was less elastic than all other sites and had increased TEWL compared to normal skin. DS skin had increased cellularity, decreased rete ridge ratios, and increased epidermal thickness compared to NS. Clinician observers and patients perceived the BS site as more severe versus DS skin through the POSAS-O, POSAS-P, and VSS. Over time, DS C and DS T sites were not different in TEWL, elasticity, erythema, MI, cellularity, RRR, epidermal thickness, POSAS-O scores, POSAS-P scores, VSS scores, or SCS scores. Over time, burn scar did not change in TEWL, elasticity, erythema, MI, POSAS-O scores, POSAS-P scores, and VSS scores. Decreased SCS scores within the DS C, DS T, and BS sites indicated patient-perceived improvement in all scars throughout the study time course. NS and DS skin possess inherent physiological differences, though not to the degree of burn scars vs. NS. FLSR may not alter the rate of maturation and remodeling of DS skin compared to current SOC. While improvement in scar assessment was observed in laser-treated BS HTS, no specific control for these sites was analyzed. Due to differences in the pathophysiology of HTS formation at grafted and donor sites, the STSG DS may not be an adequate substitute for BS HTS when designing RCTs to evaluate the effect of FLSR. Prior studies evaluating the use of FLSR in burn-related HTS consist of low-powered clinical trials or case studies without control sites or tissue-level examinations, prompting the design of an RCT in DS scars. However, this scar type may not be suitable for this study design. Future work should extend to extra-cellular matrix morphology and transcriptomics of donor site and burn scar healing to better understand the effects of laser treatment.
引用
- D'Orio CS, Carney BC, Wong JH, et al. Lessons Learned Evaluating Ablative Fractional CO2 Laser for Burn-Related Donor Site Scars. J Burn Care Res. 2025. PMID: 40067916. doi:10.1093/jbcr/iraf030
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。